A glass pitcher and a glass of water on a wooden table with notebooks, glasses, and a window in the background.

Bridging the Gap Between Healthcare Innovation & Clinical Execution

Strategic clinical advisory for HealthTech innovators, venture capital, and enterprise healthcare networks. Optimizing throughput, mastering utilization management, and scaling clinical technology for measurable financial impact.

Utkarsh Singh M.D. ACPA-C

Advisory Services

HealthTech & AI Strategy

Accelerate product-market fit. Providing fractional clinical advisory to digital health and AI vendors to build and deploy solutions that seamlessly integrate into complex hospital workflows and maximize clinical adoption.

Schedule Consultation

Clinical Due Diligence

High-margin care model transformation. Designing robust physician structures and utilization management strategies engineered to aggressively reduce Length of Stay (LOS), optimize resource use, and protect hospital operating margins.

Schedule Consultation

Throughput & Operations

De-risk your healthcare investments. Delivering rigorous operational and clinical due diligence for Venture Capital and Private Equity firms evaluating early to growth-stage healthcare acquisitions.

Schedule Consultation


Executive Leadership. Clinical Credibility.

A man in a blue checked blazer and white shirt smiling at the camera against a plain white background.

Real healthcare transformation requires a leader who understands both the balance sheet and the bedside. As an active medical director navigating the complexities of enterprise clinical operations, digital health implementation, and network utilization, I understand the friction points that stall corporate growth and technology adoption.

My advisory practice bridges the gap between high-level strategy and real-world clinical execution. By combining a deep understanding of physician workflows with rigorous executive training in health administration, I provide actionable, data-driven insights that de-risk investments, scale technologies, and protect operating margins.

Executive Advisory Inquiry